首站-论文投稿智能助手
典型文献
Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells
文献摘要:
Dear Editor, Influenza B viruses(IBVs)have circulated among humans for more than 80 years.Seasonal influenza virus epidemics caused by two IBV lines(Victoria and Yamagata)and influenza A virus have considerable effects on public health globally and result in approximately 290,000-650,000 annual influenza-attributed deaths(Caini et al.,2015;Pan et al.,2015).Currently,the most effective countermeasures against influenza B virus infections are influenza virus vaccines(Subbarao and Matsuoka,2013).However,these vaccines have limited efficacy because only strain-matched humoral immune responses are induced,while the globular head domain of viral hemagglutinin(HA)continues to evolve rapidly.In addition,few anti-influenza drugs are available,and the treatment window for administering the available drugs is small(Subbarao and Matsuoka,2013;van de Sandt et al.,2015).A universal drug that targets both influenza B virus lineages remains a public health priority.Conferring passive immune protection using broadly neutral-izing antibodies(bnAbs)may be a promising alternative viral infection treatment(Wilson and Andrews,2012;Corti and Lanzavecchia,2013;Walker and Burton,2018).
文献关键词:
作者姓名:
Yuanzhi Chen;Chenguang Shen;Jing Chen;Junyu Chen;Fentian Chen;Limin Zhang;Xue Liu;Siyuan Chen;Sen Xue;Yongliang Liu;Jixian Tang;Quan Yuan;Yixin Chen;Wenxin Luo;Ningshao Xia
作者机构:
National Institute of Diagnostics and Vaccine Development in Infectious Diseases,State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics,School of Public Health&School of Life Science,Xiamen University,Xiamen 361102,China;Biosafety Level-3 Laboratory,School of Public Health,Southern Medical University,Guangzhou 510515,China
文献出处:
引用格式:
[1]Yuanzhi Chen;Chenguang Shen;Jing Chen;Junyu Chen;Fentian Chen;Limin Zhang;Xue Liu;Siyuan Chen;Sen Xue;Yongliang Liu;Jixian Tang;Quan Yuan;Yixin Chen;Wenxin Luo;Ningshao Xia-.Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells)[J].中国病毒学,2022(04):619-622
A类:
hybridoma, Influenza,IBVs,Caini,Subbarao,Matsuoka,Sandt,bnAbs,Lanzavecchia
B类:
Development,functional,antibodies,against,influenza,by,activation,induced,cytidine,deaminase,cells,Dear,Editor,viruses,have,circulated,among,humans,more,than,years,Seasonal,epidemics,caused,two,lines,Victoria,Yamagata,considerable,effects,public,health,globally,result,approximately,annual,attributed,deaths,Pan,Currently,most,effective,countermeasures,infections,are,vaccines,However,these,limited,efficacy,because,only,strain,matched,humoral,immune,responses,while,globular,head,domain,viral,hemagglutinin,HA,continues,evolve,rapidly,addition,few,drugs,available,treatment,window,administering,small,van,universal,that,targets,both,lineages,remains,priority,Conferring,passive,protection,using,broadly,neutral,izing,may,promising,alternative,Wilson,Andrews,Corti,Walker,Burton
AB值:
0.598511
相似文献
Large-scale chemical screen identifies Gallic acid as a geroprotector for human stem cells
Hezhen Shan;Lingling Geng;Xiaoyu Jiang;Moshi Song;Jianxun Wang;Zunpeng Liu;Xiao Zhuo;Zeming Wu;Jianli Hu;Zhejun Ji;Si Wang;Piu Chan;Jing Qu;Weiqi Zhang;Guang-Hui Liu-State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;School of Life Sciences,Beijing University of Chinese Medicine,Beijing 100029,China;Advanced Innovation Center for Human Brain Protection,National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;University of Chinese Academy of Sciences,Beijing 100049,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;Sino-Danish College,University of Chinese Academy of Sciences,Beijing 101408,China
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
Li Jingxin;Zhang Li;Bao Linlin;Wang Yuxiao;Qiu Lin;Hu Jialei;Tang Rong;Yu Huiyan;Shan Jun;Li Yan;Qin Chuan;Zhu Fengcai-Department for Vaccine Clinical Evaluation, NHC Key Laboratory of Enteric Pathogenic Microbiology, Jlangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu 210009, China;Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC); Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, Beijing 100101, China;Department of Public Health, Southeast University, Nanjing, Jiangsu 210009, China;Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
Li Shuang;Moog Christiane;Zhang Tong;Su Bin-Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Laboratoire d' ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg 67000, France
Biopharmaceuticals for prevention of COVID-19: A scoping review
Afsaneh Farjami;Soheila Montazersaheb;Saiedeh Razi Soofiyani;Parvin Akbarzadehlaleh;Sara Salatin-Food and Drug Safety Research Center, Tabriz University of Medical Science, Tabriz, Iran;Pharmaceutical Analysis Research Center, Tabriz University of Medical Science, Tabriz, Iran;Molecular Medicine Research Center, Tabriz University of Medical Science, Tabriz, Iran;Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran;Clinical Research Development Unit Sina Educational, Research and Treatment Center, Tabriz University of Medical Sciences, Tabriz, Iran;Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran;Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran
Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo
Mengjiao Li;Zi-Wei Ye;Kaiming Tang;Liang Guo;Wenwen Bi;Yuyuan Zhang;Yan-dong Tang;Guoguang Rong;Mohamad Sawan;Xin Yin;Ren Sun;Shuofeng Yuan;Bobo Dang-Fudan University,Shanghai,China;Key Laboratory of Structural Biology of Zhejiang Province,School of Life Sciences,Westlake University,Hangzhou,Zhejiang,China;Center for Infectious Disease Research,Westlake Laboratory of Life Sciences and Biomedicine,Hangzhou,Zhejiang,China;Institute of Biology,Westlake Institute for Advanced Study,Hangzhou,Zhejiang,China;Department of Microbiology,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China;State Key Laboratory of Emerging Infectious Diseases,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China;State Key Laboratory of Veterinary Biotechnology,Harbin Veterinary Research Institute,Chinese Academy of Agricultural Sciences,Harbin,China;CenBRAIN Lab.,School of Engineering,Westlake University,Hangzhou,Zhejiang,China;CenBRAIN Lab.,Westlake Institute for Advanced Study,Hangzhou,Zhejiang,China;School of Biomedical Sciences,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pokfulam,Hong Kong,China
Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD—ACE2 complexes in living cells by competitive binding
Lu Miao;Wei Zhou;Chunyu Yan;Yuebin Zhang;Qinglong Qiao;Xuelian Zhou;Yingzhu Chen;Guangying Wang;Zhen-dong Guo;Jun Liu;Hailong Piao;Xia Pan;Mengxue Yan;Weijie Zhao;Guohui Li;Yueqing Li;Zhaochao Xu-CAS Key Laboratory of Separation Science for Analytical Chemistry,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;State Key Laboratory of Molecular Reaction Dynamics,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Institute of Military Veterinary Science,The Academy of Military Medical Science of PLA,Changchun 130000,China;State Key Laboratory of Fine Chemicals,Department of Pharmaceutical Sciences,School of Chemical Engineering,Dalian University of Technology,Dalian 116024,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。